Helix Pain Relieving Cream recalled nationwide for manufacturing process violations
Parker Laboratories is recalling Helix Pain Relieving Cream due to manufacturing process deviations. The voluntary recall affects multiple package sizes distributed nationwide and internationally.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall due to manufacturing process violations (CGMP deviations), voluntarily initiated by the manufacturer. No illnesses, injuries, or hospitalizations are reported. FDA Class II recalls without hospitalization reports typically score as Moderate severity per the rubric.
Plain-English summary
Parker Laboratories, Inc. recalled Helix Pain Relieving Cream (Menthol 7.4%) due to manufacturing process deviations. The product is available in multiple package sizes: 5 gram pouches, 3 fluid ounce roll-ons, 4 fluid ounce tubes, 12 fluid ounce pump bottles, 32 fluid ounce pump bottles, 1 gallon pump bottles, and starter kits.
The recall was initiated because the manufacturer identified deviations from Current Good Manufacturing Practice (CGMP) standards during production. These manufacturing process violations can affect product quality and safety.
The recalled product was distributed nationwide within the United States, as well as to Singapore, Korea, and Hong Kong. Approximately 250 units were involved in this recall. The recall was initiated on August 2, 2023, and was terminated on June 3, 2024.
Consumers who have purchased Helix Pain Relieving Cream with the affected lot codes should stop using the product. Refer to the FDA or contact Parker Laboratories for information about product replacement or return options.
The recalled product
- Product
- Helix Pain Relieving Cream (Menthol 7.4%), packaged in a) 5 gm pouch (NDC 30775-051-01), b) 3 fl. oz. roll-on (NDC 30775-051-03), c) 4 fl. oz. tubes (NDC 30775-051-04), d) 12 fl oz pump bottles (NDC 30775-051-12), e) 32 fl. oz. pump bottles (NDC 30775-051-32), f) 1 U.S. gallon wi
- Manufacturer
- Parker Laboratories, Inc.
- Category
- Drug — Topical Pain Relief
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- a) J0721010
- Exp. Date 6/30/2024
- J1022017
- Exp. Date 10/27/2025
- b) A0521002
- Exp. Date 4/29/2024
- c) A0322006
- Exp. Date 3/2/2025
- A0323004
- Exp. Date 2/24/2026
- A0422005
- Exp. Date 3/14/2025
- A0521001
- A0822004
- Exp. Date 7/27/2025
- d) C0222001
- Exp. Date 6/30/2023
- C0521003
- Exp. Date 4/29/2023
- C0822005
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27